Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Adv Drug Deliv Rev. 2014 Nov 29;84:45–67. doi: 10.1016/j.addr.2014.11.018

Figure 2.

Figure 2

ALP staining (blue) of C2C12 cells on 5 mm decellularized skin discs printed with bioactive factors resulting from (A-C) varying amounts of BMP-2 printed on the right halves of the scaffolds, (D-F) BMP-2 printed uniformly on the scaffolds with inhibitors printed on the left halves, (G) GDF-5 printed on the left halves, BMP-2 on the right halves, as well as (H) on a square piece with increasing number of BMP-2 overprints (OP). Adapted, with permission, from Cooper, et al. [179]. Copyright Mary Ann Liebert, Inc. 2010.